Rigel Pharmaceuticals | RIGL - 销售成本





销售成本 更改 日
Agenus USD 642K 399K 2025-09
Amgen USD 1.79B 128M 2025-12
Anika Therapeutics USD 11.44M 797K 2025-12
AstraZeneca USD 3.27B 471M 2025-12
BioMarin Pharmaceutical USD 161.56M 16.62M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Celldex Therapeutics USD 54.2M 8.94M 2025-06
Daiichi Sankyo JPY 118.28B 37.7B 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Halozyme Therapeutics USD 102.15M 29.14M 2025-12
Heron Therapeutics USD 11.12M 795K 2025-12
Intrexon USD 1.01M 344K 2024-06
Ionis Pharmaceuticals USD 8M 5.66M 2025-12
Karyopharm Therapeutics USD 37.43M 2.41M 2024-09
Ligand Pharmaceuticals USD 11.9M 733K 2025-09
MacroGenics USD 10.12M 34.18M 2025-12
Neurocrine Biosciences USD 17.6M 246.4M 2025-12
Pfizer USD 6.29B 2.12B 2025-12
Regeneron Pharmaceuticals USD 584.6M 63M 2025-12
Rigel Pharmaceuticals USD 8.03M 5.22M 2024-09
Sangamo BioSciences 2.42M 1.11M 2024-06
Ultragenyx Pharmaceutical USD 29M 1.01M 2025-12
Veracyte USD 39.28M 1.93M 2025-12